{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:18:22Z","timestamp":1791429502236,"version":"4.3.3"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4662,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1093\/annonc\/mdl413","type":"journal-article","created":{"date-parts":[[2006,12,21]],"date-time":"2006-12-21T21:11:14Z","timestamp":1166735474000},"page":"546-550","source":"Crossref","is-referenced-by-count":134,"title":["Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies"],"prefix":"10.1016","volume":"18","author":[{"given":"H.T.","family":"Mouridsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.W.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Buter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Eidtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Knoblauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Dahlstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.B.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1093\/annonc\/mdl413_bb0010","doi-asserted-by":"crossref","first-page":"iii26","DOI":"10.1093\/annonc\/mdg744","article-title":"Extravasation: a dreaded complication of chemotherapy","volume":"14","author":"Schrijvers","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl413_bb0015","first-page":"3680","article-title":"Treatment of anthracycline extravasation with dexrazoxane","volume":"6","author":"Langer","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdl413_bb0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1023\/A:1011163823321","article-title":"Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice","volume":"12","author":"Langer","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl413_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00280-005-0022-7","article-title":"Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone","volume":"57","author":"Langer","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/mdl413_bb0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/028418601750288299","article-title":"A new conservative approach to extravasation of anthracyclines with dimethylsulfoxide and dexrazoxane","volume":"40","author":"Bos","year":"2001","journal-title":"Acta Oncol"},{"key":"10.1093\/annonc\/mdl413_bb0035","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1470-2045(04)01470-6","article-title":"Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing","volume":"5","author":"El Saghir","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdl413_bb0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/02844310310007791","article-title":"Dexrazoxane\u2014a promising antidote in the treatment of accidental extravasation of anthracyclines","volume":"37","author":"Jensen","year":"2003","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"10.1093\/annonc\/mdl413_bb0045","first-page":"3064","article-title":"Dexrazoxane in anthracycline extravasation","volume":"18","author":"Langer","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl413_bb0050","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/1097-0142(19810415)47:8<1959::AID-CNCR2820470808>3.0.CO;2-X","article-title":"Phase I evaluation of ICRF-187 (NSC 169780) in patients with advanced malignancy","volume":"47","author":"Liesmann","year":"1981","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdl413_bb0055","first-page":"249","article-title":"Phase I study of ICRF-187 using a daily for 3 days schedule","volume":"65","author":"Von Hoff","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/annonc\/mdl413_bb0060","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/1097-0142(197711)40:5<2053::AID-CNCR2820400509>3.0.CO;2-A","article-title":"Clinical course and management of accidental adriamycin extravasation","volume":"40","author":"Reilly","year":"1977","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdl413_bb0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00000637-200210000-00006","article-title":"Retrospective study of the management of chemotherapeutic extravasation injury","volume":"49","author":"Langstein","year":"2002","journal-title":"Ann Plast Surg"},{"key":"10.1093\/annonc\/mdl413_bb0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jso.2930230409","article-title":"Adriamycin extravasation: surgical treatment and possible prevention of skin and soft-tissue injuries","volume":"23","author":"Pitkanen","year":"1983","journal-title":"J Surg Oncol"},{"key":"10.1093\/annonc\/mdl413_bb0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00000637-198710000-00005","article-title":"Cytostatic extravasations","volume":"19","author":"Preuss","year":"1987","journal-title":"Ann Plast Surg"},{"key":"10.1093\/annonc\/mdl413_bb0080","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/1097-0142(19820501)49:9<1796::AID-CNCR2820490911>3.0.CO;2-M","article-title":"Treatment of tissue extravasation by antitumor agents","volume":"49","author":"Larson","year":"1982","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdl413_bb0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0006-2952(93)90514-W","article-title":"Antagonistic effect of the cardioprotector (+)-1,2,-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16)","volume":"46","author":"Sehested","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1093\/annonc\/mdl413_bb0090","first-page":"459","article-title":"Phase I trial of ICRF-187 by 48-hour continuous infusion","volume":"65","author":"Koeller","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/annonc\/mdl413_bb0095","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/1097-0142(197609)38:3<1087::AID-CNCR2820380308>3.0.CO;2-X","article-title":"Skin ulcers due to adriamycin","volume":"38","author":"Rudolph","year":"1976","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdl413_bb0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00006534-197801000-00015","article-title":"Adriamycin extravasation","volume":"61","author":"Bowers","year":"1978","journal-title":"Plast Reconstr Surg"},{"key":"10.1093\/annonc\/mdl413_bb0105","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1200\/JCO.1987.5.7.1116","article-title":"Etiology and treatment of chemotherapeutic agent extravasation injuries: a review","volume":"5","author":"Rudolph","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl413_bb0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0268-960X(90)90015-K","article-title":"Antidotes to vesicant chemotherapy extravasations","volume":"4","author":"Dorr","year":"1990","journal-title":"Blood Rev"},{"key":"10.1093\/annonc\/mdl413_bb0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00006534-198407000-00019","article-title":"The delineation of adriamycin extravasation using fluorescence microscopy","volume":"74","author":"Bleicher","year":"1984","journal-title":"Plast Reconstr Surg"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419378202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419378202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/18\/3\/546\/1347028\/mdl413.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T06:19:07Z","timestamp":1582179547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419378202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0923753419378202"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdl413","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}